Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma.

Cite this paper

@article{Kewalramani2004RituximabAI, title={Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma.}, author={Tarun Kewalramani and Andrew D. Zelenetz and Stephen D. Nimer and Carol S. Portlock and David J. Straus and Ariela Noy and Owen O'Connor and Daniel A. Filippa and Julie Teruya-Feldstein and Alison N Gencarelli and Jing Qin and Alyson Waxman and Joachim Yahalom and Craig H. Moskowitz}, journal={Blood}, year={2004}, volume={103 10}, pages={3684-8} }